Publication | Closed Access

A randomized, placebo-controlled trial of varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers

Tobacco CessationTobacco ControlTobacco UseNicotinePharmacologyNew TherapyPlacebo-controlled TrialPharmacotherapyPharmacologic InterventionPublic HealthMedicineAsian Smokers